DARLENE D SAMPSON
Allopathic & Osteopathic Physicians|Internal Medicine LONG BEACH, CA NPI 1962593822
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine CA Amgen Inc. All categories
General Payments — all program years on this page
$5,291.11
- Category: General Payments
- Program years: PY2018–2024
- Record count: 124
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,101.31 across 19 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,101.31 | 19 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $447.85 | 5 |
| UCB, Inc. | $356.39 | 12 |
| Galderma Laboratories, L.P. | $172.24 | 1 |
| PFIZER INC. | $124.83 | 1 |
By program year
Records — PY2024 (19)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1117373182 | Amgen Inc. | $142.76 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117373184 | Amgen Inc. | $142.76 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117373186 | Amgen Inc. | $121.71 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117373188 | Amgen Inc. | $17.55 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117373190 | Amgen Inc. | $23.07 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131484742 | PFIZER INC. | $124.83 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018157 | UCB, Inc. | $5.75 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018159 | UCB, Inc. | $5.65 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018161 | UCB, Inc. | $21.45 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018163 | UCB, Inc. | $28.25 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018165 | UCB, Inc. | $20.00 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018167 | UCB, Inc. | $26.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018169 | UCB, Inc. | $124.99 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018171 | UCB, Inc. | $19.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018173 | UCB, Inc. | $27.00 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018175 | UCB, Inc. | $29.00 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018177 | UCB, Inc. | $26.30 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143018179 | UCB, Inc. | $23.00 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145325901 | Galderma Laboratories, L.P. | $172.24 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.